Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wunderink

Showing results (411-420 of 545) with videos related to

Pageof 55
Sort By:
Intensive Care Medicine|November 23, 2021
Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trialG Bellingan, F Jacono, J Bannard-Smith, et al.
Journal of Clinical Microbiology|November 1, 2016
Improved Detection of Respiratory Pathogens by Use of High-Quality Sputum with TaqMan Array Card TechnologyBernard J Wolff, Anna M Bramley, Kathleen A Thurman, et al.
Journal of Clinical Microbiology|December 17, 2020
Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage FluidMatthias Klein, Johannes Bacher, Sandra Barth, et al.
The Lancet. Infectious Diseases|October 15, 2020
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trialMatteo Bassetti, Roger Echols, Yuko Matsunaga, et al.
The Lancet. Infectious Diseases|December 24, 2019
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trialMichael S Niederman, Jeff Alder, Matteo Bassetti, et al.
Vascular Medicine (London, England)|May 4, 2017
Pulmonary hospitalizations and ischemic heart disease events in patients with peripheral artery diseaseMary McGrae McDermott, Lu Tian, Richard G Wunderink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2008
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI SummitMarin H Kollef, Lena M Napolitano, Joseph S Solomkin, et al.
Chest|June 8, 2013
Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohortsSachin Yende, Karina Alvarez, Laura Loehr, et al.
Annals of the American Thoracic Society|March 16, 2026
Comparing Clinical Assessments of Pneumonia to Bronchoalveolar Lavage Results in Critically Ill Patients With Suspected PneumoniaCaroline F Zhao, Catherine A Gao, Helen K Donnelly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2020
Parainfluenza Virus Types 1-3 Infections Among Children and Adults Hospitalized With Community-acquired PneumoniaLeigh M Howard, Kathryn M Edwards, Yuwei Zhu, et al.
Pageof 55

Showing results (411-420 of 545) with videos related to

Sort By:
Pageof 55
Intensive Care Medicine|November 23, 2021
Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trialG Bellingan, F Jacono, J Bannard-Smith, et al.
Journal of Clinical Microbiology|November 1, 2016
Improved Detection of Respiratory Pathogens by Use of High-Quality Sputum with TaqMan Array Card TechnologyBernard J Wolff, Anna M Bramley, Kathleen A Thurman, et al.
Journal of Clinical Microbiology|December 17, 2020
Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage FluidMatthias Klein, Johannes Bacher, Sandra Barth, et al.
The Lancet. Infectious Diseases|October 15, 2020
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trialMatteo Bassetti, Roger Echols, Yuko Matsunaga, et al.
The Lancet. Infectious Diseases|December 24, 2019
Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trialMichael S Niederman, Jeff Alder, Matteo Bassetti, et al.
Vascular Medicine (London, England)|May 4, 2017
Pulmonary hospitalizations and ischemic heart disease events in patients with peripheral artery diseaseMary McGrae McDermott, Lu Tian, Richard G Wunderink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2008
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI SummitMarin H Kollef, Lena M Napolitano, Joseph S Solomkin, et al.
Chest|June 8, 2013
Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohortsSachin Yende, Karina Alvarez, Laura Loehr, et al.
Annals of the American Thoracic Society|March 16, 2026
Comparing Clinical Assessments of Pneumonia to Bronchoalveolar Lavage Results in Critically Ill Patients With Suspected PneumoniaCaroline F Zhao, Catherine A Gao, Helen K Donnelly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2020
Parainfluenza Virus Types 1-3 Infections Among Children and Adults Hospitalized With Community-acquired PneumoniaLeigh M Howard, Kathryn M Edwards, Yuwei Zhu, et al.
Pageof 55